COMP <GO>
MLI vs TMO // FREE CASH FLOW YIELD
Mueller Industries Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MLI 10
— TMO 3
▲ FREE CASH FLOW YIELD LEADER: MLI
LAST: $54.56 (-2.19%) • MKT CAP: $12.16B
fcf-yield
4.67%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
fcf-yield
2.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MLI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MLI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 41.10% | 9.30% | +31.80 | MLI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.6x | 30.4x | -20.80 | MLI | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 4.67% | 2.40% | +2.27 | MLI | /fcf-yield <GO> |
| Operating Margin | 22.90% | 17.40% | +5.50 | MLI | /operating-margins <GO> |
| Net Profit Margin | 18.30% | 15.10% | +3.20 | MLI | /net-margins <GO> |
| Revenue Growth (YoY) | 10.90% | 3.90% | +7.00 | MLI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.90% | 0.24% | +0.66 | MLI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 18.71 | 4.50 | +14.21 | MLI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.70% | +0.50 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.1 | 59.1 | -26.09 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.94 | +0.16 | MLI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 14.8x | 36.3x | -21.50 | MLI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.16B | $262.22B | -$250.06B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MLI REV | TMO REV | MLI GROSS % | TMO GROSS % | MLI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.18B | $44.56B | 44.0% | 44.0% | $567.4M | $6.29B |
| FY 2024 | $3.77B | $42.88B | 44.0% | 44.0% | $476.3M | $7.27B |
| FY 2023 | $3.42B | $42.86B | 44.0% | 44.0% | $518.9M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MLI // BETA 1.10
TMO // BETA 0.94